Septerna names Rajiv Patni, M.D. as Chief Medical Officer
The GPCR-focused biotech's board appointed the physician-executive effective August 24, 2026, filling out its clinical leadership team.
SEC filing
Latest
2 stories
Tuesday, August 25
Monday, August 10
Septerna reports Q2 2026 results, sees SEP-479 pharmacokinetics support once-daily dosing
The company said its Phase 1 SEP-479 trial data support once-daily dosing, with full SAD/MAD results expected in the first quarter of 2027.
SEC filing